Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 8, 1996, Pages 941-947

  Surguchov, Andrei P ^a   Page, Grier P ^b   Smith, Louis ^a   Patsch, Wolfgang ^c   Boerwinkle, Eric ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

apo C III; cholesterol; haplotypes; NIDDM; triglycerides

Indexed keywords

APOLIPOPROTEIN C3; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DNA FLANKING REGION; FEMALE; GENE CLUSTER; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029791892     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.8.941     Document Type: Article

References (57)

1. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Faergeman O, Humphries SE. Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis. 1993;100:157-169.
2. Shoulders CC, Harry PJ, Lagrost L, White SE, Shah NF, North JD, Gilligan M, Gambert P, Ball MJ. Variation at the apo AI-CIII-AIV gene complex is associated with elevated plasma apo CIII. Atherosclerosis. 1991;87:238-247.
3. Crique MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S, Kritchevsky S, Jacobs DR, O'Grady HK, Davis CE. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 1993;328:1220-1225.
4. De Lorenzo F, Monticelli A, Cocozza S, De Simone B, Rubba P. Extracoronary atherosclerosis and genetic variants of apolipoprotein AI-CIII cluster in myocardial infarction survivors from southern Italy. Clin Invest. 1994;72:435-441.
5. Rees A, Stocks J, Sharpe CR, Vella MA, Shoulders CC, Katz J, Jowett NI, Barelle FE, Galton DJ. Deoxynucleic acid polymorphism in the apolipoprotein AI-CIII gene cluster. J Clin Invest. 1985;76:1090-1095.
6. Bruns GA, Karathanasis SK, Breslow JL. Human apolipoprotein AI-CIII gene complex is located on chromosome 11. Arteriosclerosis. 1984;4:97-102.
7. Aalto-Settälä K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) C-III transgenic mice: diminished very low density lipoprotein fractional catabolic rate associated with increased apo C-III and reduced apo E on the particles. J Clin Invest. 1992;90:1889-1890.
8. Wang CS, McConathy WJ, Kloer HU, Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins: effect of apolipoprotein C-III. J Clin Invest. 1985;75:383-390.
9. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science. 1990;249:790-793.
10. Maeda N, Li H, Lee D, Oliver P, Quarford SH, Osada J. Targeted disruption of the apolipoprotein CIII gene in mice results in hypertriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem. 1994;269:23610-23616.
11. Ordovas JM, Civeira F, Genest JJ, Craig S, Robbins AH, Maede T, Pocovi M, Frossard PM, Masharani U, Wilson PWF, Salem DN, Ward RH, Schaefer EJ. Restriction fragment length polymorphisms of the apolipoprotein AI-CIII-AIV gene locus. Atherosclerosis. 1991;87:75-86.
12. Rees A, Stocks J, Shoulders CC, Galton DJ, Baralle FE. DNA polymorphism adjacent to human apoprotein A-I gene: relation to hypertriglyceridaemia. Lancet. 1983;1:444-446.
13. Tas S. Strong association of a single nucleotide substitution in the 3′-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs. Clin Chem. 1989;35:256-259.
14. Zeng Q, Dammerman M, Takada Y, Matsunaga A, Breslow JL, Sasaki J. An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum Genet. 1995;95:361-375.
15. Schonfeld G, George PK, Miller J, Reilly P, Witztum J. Apolipoprotein C-II and C-III levels in hyperlipoproteinemia. Metabolism. 1979;28:1001-1010.
16. The ARIC Investigators. The atherosclerosis risk in communities (ARIC) study: design and objectives. Am J Epidemiol 1989;129:687-702.
17. Brown SA, Hutchinson R, Morrisett J, Boerwinkle E, Davis CE, Gotto AM, Patsch W. Plasma lipid, lipoprotein cholesterol and apoprotein distributions in selected US communities. Arterioscler Thromb. 1993;13:1139-1158.
18. Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
19. Miller SA, Dyker DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215-1221.
20. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci U S A. 1993;90:4562-4566.
21. Surguchov AP, Liu S-B, Patsch W. Simple non-radioactive method of analysis of polymorphic markers flanking apolipoprotein CIII gene. Biochem Mol Biol Int. 1995;submitted.
22. Patsch W, Sharrett AR, Chen IY, Lin-Lee Yen-C, Brown S, Gotto AM, Boerwinkle E. Associations of allelic differences at the A-I/C-III/A-IV gene cluster with carotid artery intimal-media thickness and plasma lipid transport in hypercholesterolemic-hypertriglyceridemic humans. Arterioscler Thromb. 1994;14:874-883.
23. Siedel J, Hagele E, Ziegenhorn J, Wahlefeld AW. Reagents for enzymatic determination of serum cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075-1080.
24. Nagele U, Hagele E, Sauer G, Wiedermann E, Wahlfeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglyceride with improved lipolytic efficiency. J Clin Chem Biochem. 1984;22:165-174.
25. Warnick GR, Benderson J, Alberts JJ. Quantitation of high-density lipoprotein subclass after separation by dextran sulfate and magnesium precipitation. Clin Chem. 1982;28:1574.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma, without use of preparative ultracentrifugation. Clin Chem. 1972;18:499-502.
27. Brown SA, Rhodes CE, Dunn K, Gotto AM, Patsch W. Effect of blood collection and processing on radioimmunoassay results for apolipoprotein AI in plasma. Clin Chem. 1988;34:920-924.
28. Brown SA, Epps DF, Dunn JK, Sharett AR, Patsch JR, Gotto AM, Patsch W. Effect of blood collection and processing on radioimmunoassay results for apolipoprotein B in plasma. Clin Chem. 1990;36:1662-1666.
29. Gaubetz JW, Cushing GL, Morrisett JD. Quantitation, isolation, and characterization of human lipoprotein [a]. Methods Enzymol. 1986;129:167-186.
30. Guo W, Thompson EA. Monte Carlo Estimation of P-Value for Sparse Contingency Tables. Technical Report #187. Seattle, Wash: University of Washington; 1987.
31. Terwilliger JD, Ott J. Handbook of Genetic Linkage. Baltimore, Md; Johns Hopkins Press: 1994.
32. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics. 1987;117:331-341.
33. Federer WT, Zelen M. Analysis of multifactorial classification with unequal numbers of observations. Biometrics. 1966;22:525-552.
34. Schlesselman JJ. Case-Control Studies. New York, NY: Oxford University Press; 1982.
35. Renard E, Dupuy AM, Monnier L, Craster de Paulet A. DNA restriction polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster: a genetic determination of atherosclerosis in type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med. 1991;8:354-360.
36. Benlian P, Boileau C, Loux N, Pastier D, Masliah J, Coulon M, Nigou M, Ragab A, Guimard J, Ruiavets JB, Bonaiti-Pellie C, Fruchart JC, Douste-Blazy P, Berziat G, Junien C. Extended haplotypes and linkage disequilibrium between 11 markers at the apo AI-CIII-AIV gene cluster on chromosome 11. Am J Hum Genet. 1991;48:903-910.
37. Haviland MB, Kessling AM, Davignon J, Sing CF. Estimation of Hardy-Weinberg and pairwise disequilibrium in the apolipoprotein AI-CIII-AIV gene cluster. Am J Hum Genet. 1991;49:350-365.
38. Wojciechowski AP, Farrall M, Cullen P, Wilson TME, Bayliss JD, Farren P, Griffin BA, Caslake MJ, Packard CJ, Shepherd J, Thakker R, Scott J. Familial combined hyperlipidemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-q24. Nature. 1991;349:161-164.
39. Xu C-F, Talmud P, Schuster H, Houlston R, Miller G, Humphries S. Association between genetic variation at the apo AI-CIII-AIV gene cluster and familial combined hyperlipidemia. Clin Genet. 1994;46:385-397.
40. Price WH, Morris SW, Burgon R, Donald PM, Kitchin AH. Apolipoprotein CIII polymorphism and coronary heart disease. Lancet. 1986;2:1041. Letter.
41. Rees A, Stocks J, Paul H, Ohuchi Y, Galton D. Haplotypes identified by DNA polymorphisms at the apolipoprotein AI and CIII loci and hypertriglyceridemia: a study in a Japanese population. Hum Genet. 1986;72:168-171.
42. Henderson HE, Landon SV, Michie J, Berger GMB. Association of a DNA polymorphism in the apolipoprotein CIII gene with diverse hyperlipidaemic phenotypes. Hum Genet. 1987;75:62-65.
43. Stocks J, Paul H, Galton D. Haplotypes identified by DNA restriction-fragmen-length polymorphisms in the AI-CIII-AIV gene region and hypertriglyceridemia. Am J Hum Genet. 1987;41:106-118.
44. Ahn YI, Valdez R, Reddy AP, Cole SA, Weiss KM, Ferrell RE. DNA polymorphisms of the apolipoprotein AI/CIII/AIV gene cluster influences plasma cholesterol and triglyceride levels in the Mayans of the Yucatan peninsula, Mexico. Hum Hered. 1991;41:281-289.
45. Johansen K, Dunn B, Tan JCY, Kwassi AAA, Skotnicki A, Skootnicki M. Coronary artery disease and apolipoprotein AI-CIII gene polymorphism: a study of Saudi Arabians. Clin Genet. 1991;39:1-5.
46. Paul-Hayase H, Rosseneu M, Robinson D, Van Bervliet JP, Deslypere JP, Humphriss SE. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII, and apo AIV concentrations. Hum Genet. 1992;88:439-446.
47. Bai H, Saku K, Liu R, Imamura M, Arakawa K. Association between coronary heart disease and the apolipoprotein AI-CIII-AIV complex in a Japanese population. Hum Genet. 1995;95:102-104.
48. Cole SA, Szathmary EJE, Ferrell RE. Gene and gene-product variation in the apolipoprotein AI-CIII-AIV cluster in the Dogrib Indians of the Northwest Territories. Am J Hum Genet. 1989;44:835-843.
49. De Lorenzo F, Monticelli A, Cocozza S. SstI apo AI-CIII DNA polymorphism associated with lower levels of HDL cholesterol in a young population from south of Italy. Aust N Z J Med. 1993;23:711-712.
50. Malmendier CL, Lontie JF, Delcroix C, Dubois DY, Magot T, de Roy L. Apolipoprotein C-II and C-III metabolism in hypertriglyceridemic patients: effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration. Atherosclerosis. 1989;77:139-149.
51. De Suva HV, Lauer SJ, Wang J, Simonet WS, Weisgraber KH, Mahley RW, Taylor JM. Overexpression of human apolipoprotein CIII in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J Biol Chem. 1994;269:2324-2335.
52. Reue K, Leff T, Breslow JL. Human apolipoprotein CIII gene is regulated by positive and negative cis-acting elements and tissue-specific protein factors. J Biol Chem. 1988;263:6857-6964.
53. Chen M, Breslow JL, Li W, Leff T. Transnational regulation of the apo CIII gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels. J Lipid Res. 1994;35:1918-1924.
54. Gruber PJ, Torres-Rosado A, Wolak ML, Leff T. Apo CIII transcription is regulated by a cytokine inducible NF-kB element. Nucleic Acids Res. 1994;22:2417-2422.
55. Ogami K, Hadzopoulou-Cladaras M, Cladaras C, Zannis VI. Promoter elements and factors required for hepatic and intestinal transcription of the human apo CIII gene. J Biol Chem. 1990;265:9808-9815.
56. Beutler B, Brown T. Polymorphism of the mouse TNF-a locus: sequence of the 3′-untranslated region and first intron. Gene. 1993;129:279-283.
57. Zaidi SHE, Denman R, Malter JS. Multiple proteins interact at a unique cis-element in the 3′-untranslated region of amyloid precursor protein mRNA. J Biol Chem. 1994;269:35-42.